$4.22 Billion is the total value of Alphabet Inc.'s 52 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 36.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PATH | Sell | UiPath Inccl a | $924,959,000 | -53.1% | 17,581,428 | -39.4% | 21.94% | -45.4% |
| VERV | Verve Therapeutics Inc | $515,778,000 | -22.0% | 10,974,011 | 0.0% | 12.24% | -9.2% | |
| DXCM | Dexcom Inc | $440,466,000 | +28.0% | 805,681 | 0.0% | 10.45% | +49.1% | |
| OSCR | Oscar Health Inccl a | $418,105,000 | -19.1% | 24,042,864 | 0.0% | 9.92% | -5.8% | |
| LYFT | Lyft Inc | $328,944,000 | -11.4% | 6,138,154 | 0.0% | 7.80% | +3.2% | |
| New | Robinhood Mkts Inc | $323,904,000 | – | 7,697,335 | +100.0% | 7.68% | – | |
| New | Adagio Therapeutics Inc | $239,956,000 | – | 5,680,785 | +100.0% | 5.69% | – | |
| RCUS | Sell | Arcus Biosciences Inc | $142,984,000 | +12.9% | 4,100,475 | -11.1% | 3.39% | +31.4% |
| New | Duolingo Inc. | $118,499,000 | – | 712,304 | +100.0% | 2.81% | – | |
| New | Benson Hill Inc | $105,184,000 | – | 14,752,271 | +100.0% | 2.50% | – | |
| LYEL | Lyell Immunopharma Inc | $86,804,000 | -8.9% | 5,865,125 | 0.0% | 2.06% | +6.1% | |
| DM | Desktop Metal Inc. | $79,219,000 | -37.7% | 11,048,730 | 0.0% | 1.88% | -27.4% | |
| SANA | Sana Biotechnology Inc | $63,338,000 | +14.5% | 2,812,500 | 0.0% | 1.50% | +33.4% | |
| RLAY | Sell | Relay Therapeutics Inc | $51,756,000 | -22.6% | 1,641,497 | -10.1% | 1.23% | -9.8% |
| GLUE | Monte Rosa Therapeutics Inc | $32,618,000 | -1.9% | 1,464,015 | 0.0% | 0.77% | +14.3% | |
| KRON | Kronos Bio Inc | $30,145,000 | -12.5% | 1,438,232 | 0.0% | 0.72% | +1.9% | |
| BEAM | Sell | Beam Therapeutics Inc | $27,983,000 | -65.8% | 321,604 | -49.4% | 0.66% | -60.2% |
| VACC | Vaccitech PLCads | $26,828,000 | -6.2% | 1,704,444 | 0.0% | 0.64% | +9.1% | |
| MGTA | Magenta Therapeutics Inc | $24,309,000 | -25.6% | 3,339,138 | 0.0% | 0.58% | -13.2% | |
| RAPT | Sell | RAPT Therapeutics Inc | $22,053,000 | -12.1% | 710,250 | -10.0% | 0.52% | +2.3% |
| ILMN | New | Illumina Inc | $21,688,000 | – | 53,470 | +100.0% | 0.52% | – |
| IDYA | Ideaya Biosciences Inc | $19,199,000 | +21.4% | 753,187 | 0.0% | 0.46% | +41.3% | |
| New | Tenaya Therapeutics Inc | $18,909,000 | – | 915,705 | +100.0% | 0.45% | – | |
| CRTX | Cortexyme Inc | $17,325,000 | +72.9% | 189,122 | 0.0% | 0.41% | +101.5% | |
| VERA | Vera Therapeutics Inccl a | $16,392,000 | +30.8% | 944,791 | 0.0% | 0.39% | +52.5% | |
| SPRO | Spero Therapeutics Inc | $16,385,000 | +31.9% | 889,979 | 0.0% | 0.39% | +53.8% | |
| DBTX | Decibel Therapeutics Inc | $12,616,000 | -10.3% | 1,636,258 | 0.0% | 0.30% | +4.2% | |
| TSHA | Taysha Gene Therapies Inc | $11,933,000 | -12.2% | 640,882 | 0.0% | 0.28% | +2.2% | |
| New | Amplitude Inc | $10,295,000 | – | 189,447 | +100.0% | 0.24% | – | |
| New | Tscan Therapeutics Inc | $8,983,000 | – | 1,077,080 | +100.0% | 0.21% | – | |
| EVLO | Evelo Biosciences Inc | $7,466,000 | -48.8% | 1,060,495 | 0.0% | 0.18% | -40.4% | |
| OMIC | Singular Genomics Systems Inc | $7,236,000 | -59.3% | 646,622 | 0.0% | 0.17% | -52.5% | |
| FULC | Sell | Fulcrum Therapeutics Inc | $7,206,000 | +1.4% | 255,452 | -62.3% | 0.17% | +17.9% |
| FHTX | Foghorn Therapeutics Inc | $6,978,000 | +30.6% | 500,901 | 0.0% | 0.17% | +52.3% | |
| NEWR | New Relic Inc | $6,541,000 | +7.2% | 91,132 | 0.0% | 0.16% | +25.0% | |
| NVTA | New | Invitae Corp | $6,140,000 | – | 215,965 | +100.0% | 0.15% | – |
| AUTL | Autolus Therapeutics PLCspon adr | $4,574,000 | -1.3% | 698,262 | 0.0% | 0.11% | +16.0% | |
| ALEC | Alector Inc | $4,013,000 | +9.6% | 175,866 | 0.0% | 0.10% | +26.7% | |
| UBER | Uber Technologies Inc | $2,216,000 | -10.6% | 49,466 | 0.0% | 0.05% | +3.9% | |
| EXAS | New | Exact Sciences Corp | $2,215,000 | – | 23,205 | +100.0% | 0.05% | – |
| SQZ | SQZ Biotechnologies Co | $1,499,000 | -0.2% | 103,929 | 0.0% | 0.04% | +16.1% | |
| TWLO | Twilio Inccl a | $1,205,000 | -19.0% | 3,776 | 0.0% | 0.03% | -3.3% | |
| SPGI | S&P Global Inc | $252,000 | +3.7% | 592 | 0.0% | 0.01% | +20.0% | |
| CLOV | Exit | Clover Health Investments Co | $0 | – | -4,113,742 | -100.0% | -1.12% | – |
| WORK | Exit | Slack Technologies Inc. | $0 | – | -1,299,771 | -100.0% | -1.17% | – |
| ABNB | Exit | Airbnb Inc | $0 | – | -525,626 | -100.0% | -1.64% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
| 4 | 2024-04-17 |
| 4 | 2024-04-15 |
| 144 | 2024-04-12 |
| 4 | 2024-04-04 |
| 144 | 2024-04-03 |
| 144 | 2024-04-03 |
| 4 | 2024-04-02 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.